Overview of Biotech Capital Markets Through Week Ended March 24th, 2023

Let's take a look at some highlights from the Biotech and MedTech/Diagnostics Private and Public Capital Markets and SPAC Activity Through the Week Ended March 24th, 2023.

• Biotech: 3 Transactions (2 Follow-Ons and 1 Registered Direct) totaling just over $700 Million

• Med Tech: No Current Week Transactions

2023 YTD

• 37 Biotech transaction totaling just over $4.4 Billion v. 2022: 21 Biotech transactions totaling just over $3.2 Billion

• 6 Med Tech transactions totaling just over $400 Million v. 2022: 3 Med Tech transaction just over $200 Million

Private Transactions

• Biotech: 53 US Transactions / 19 European Transaction

• Med Tech: 34 US Transactions / 13 European Transaction